FDA strengthens kidney injury warning on labeling of canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga and Xigduo XR).
2016 – FDA strengthens warning label
Announcement Date: June 14, 2016
FDA strengthens kidney injury warning on labeling of canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga and Xigduo XR).